STOKE THERAPEUTICS, INC. (STOK)
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant)
CEL-SCI Announces Closing of Offering
Shopify Announces Results of its 2026 Annual Meeting of Shareholders
Robert Half honored as one of the Best Places to Work in the Bay Area
Lattice to Showcase Industry-Leading FPGA Innovations at FPGA Conference Europe 2026
THOR INDUSTRIES ANNOUNCES REGULAR QUARTERLY DIVIDEND
Track Group to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub
Investor Notice: Robbins LLP Informs Investors of the Microsoft Corporation Class Action Lawsuit
Capital Increase in Genmab as a Result of Employee Warrant Exercise